Department of Oncology and Radiotherapy, Charles University School of Medicine, Hradec Kralove, Czech Republic.
Med Oncol. 2011 Dec;28(4):1281-7. doi: 10.1007/s12032-010-9593-1. Epub 2010 Jun 22.
An increased incidence of complications of atherosclerosis has been noted in cancer survivors. The aim of the present study was to evaluate, in patients with breast carcinoma, the effect of antracycline-based chemotherapy on carotid intima-media thickness (IMT), myocardial perfusion, assessed by single-photon emission tomography (SPECT) and laboratory parameters associated with the risk of atherosclerosis. Thirty-six patients with breast cancer were evaluated before and after anthracycline-based chemotherapy. Retinol, alpha-tocopherol, glycosylated hemoglobin and urinary neopterin were measured by high-performance liquid chromatography. Peripheral blood cell count, D-dimers, fibrinogen, antithrombin, glucose, magnesium, creatinine, uric acid, albumin, C-reactive protein, lipoprotein (a), cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides, homocysteine, urinary albumin and N-acetyl-beta-D-glucosaminidase (NAG) were determined with routine methods. No significant differences were observed between patients and 16 controls. Compared to the measurement before the start of therapy, peripheral blood leukocyte and platelet count, hemoglobin, creatinine, HDL cholesterol, retinol, albumin, urinary albumin and NAG decreased, and total cholesterol, LDL cholesterol, triglycerides, neopterin and mean IMT increased significantly after the treatment. Of the 36 patients who had SPECT after treatment, perfusion defects were noted only in two cases, including the patient who had perfusion defects at baseline examination and a patient who did not have a baseline SPECT. In conclusion, a significant increase in carotid IMT, total cholesterol, LDL cholesterol, triglycerides and urinary neopterin and a decrease of peripheral blood leukocyte and platelet counts, hemoglobin, creatinine, HDL cholesterol, retinol, albumin and NAG were observed after the treatment.
癌症幸存者的动脉粥样硬化并发症发生率增加。本研究旨在评估乳腺癌患者接受蒽环类药物化疗后颈动脉内膜中层厚度(IMT)、单光子发射断层扫描(SPECT)评估的心肌灌注以及与动脉粥样硬化风险相关的实验室参数的变化。对 36 例接受蒽环类药物化疗的乳腺癌患者进行了评估。采用高效液相色谱法测定视黄醇、α-生育酚、糖化血红蛋白和尿新蝶呤。用常规方法测定外周血细胞计数、D-二聚体、纤维蛋白原、抗凝血酶、血糖、镁、肌酐、尿酸、白蛋白、C 反应蛋白、脂蛋白(a)、胆固醇、高密度脂蛋白(HDL)胆固醇、低密度脂蛋白(LDL)胆固醇、甘油三酯、同型半胱氨酸、尿白蛋白和 N-乙酰-β-D-氨基葡萄糖苷酶(NAG)。患者与 16 例对照者之间无显著差异。与治疗前相比,外周血白细胞和血小板计数、血红蛋白、肌酐、HDL 胆固醇、视黄醇、白蛋白、尿白蛋白和 NAG 降低,总胆固醇、LDL 胆固醇、甘油三酯、新蝶呤和平均 IMT 明显升高。在接受治疗后进行 SPECT 的 36 例患者中,仅在 2 例中观察到灌注缺陷,包括在基线检查中存在灌注缺陷的患者和未进行基线 SPECT 的患者。总之,治疗后颈动脉 IMT、总胆固醇、LDL 胆固醇、甘油三酯和尿新蝶呤明显升高,外周血白细胞和血小板计数、血红蛋白、肌酐、HDL 胆固醇、视黄醇、白蛋白和 NAG 降低。